Epstein-Barr virus-dependent lymphoproliferative disease: Critical role of IL-6

Sandrine Mauray, Marie Thérèse Fuzzati-Armentero, Philippe Trouillet, Marlies Rüegg, Grazia Nicoloso, Margreet Hart, Lucien Aarden, Marc Schapira, Michel A. Duchosal

Research output: Contribution to journalArticle


Epstein-Barr virus (EBV)-induced lymphoproliferative disease (lpd) is a B cell neoplasm that affects patients who are immunosuppressed in the context of organ transplantation or HIV infection. A model for the aggressive form of this entity was generated by xenotransplantation of SCID mice with human peripheral blood leukocytes from individuals with prior contact with EBV. This model, where large B cell lymphoma occurs, was used to test the hypothesis that IL-6 has a major role in EBV-induced B cell tumorigenesis. IL-6 is known to differentiate B cells into immunoglobulin-secreting plasma cells and induce EBV replication, and xenochimeric animals have detectable serum levels of human IL-6. Human IL-6 inhibition with a neutralizing monoclonal antibody decreased tumor incidence from 62% to 27%. In addition, anti-IL-6 treatment significantly improved xenotransplanted animal survival, with median survival at > 245 days when compared to that of controls at 132 days. In conclusion, IL-6 plays a critical role in the pathogenesis of EBV-induced human lpd, and IL-6 inhibition may represent a new and promising preventive or therapeutic approach against this malignancy.

Original languageEnglish
Pages (from-to)2065-2073
Number of pages9
JournalEuropean Journal of Immunology
Issue number7
Publication statusPublished - 2000


  • Epstein-Barr virus
  • IL-6
  • Lymphoproliferative disease
  • SCID mouse
  • Xenotransplantation

ASJC Scopus subject areas

  • Immunology

Fingerprint Dive into the research topics of 'Epstein-Barr virus-dependent lymphoproliferative disease: Critical role of IL-6'. Together they form a unique fingerprint.

  • Cite this

    Mauray, S., Fuzzati-Armentero, M. T., Trouillet, P., Rüegg, M., Nicoloso, G., Hart, M., Aarden, L., Schapira, M., & Duchosal, M. A. (2000). Epstein-Barr virus-dependent lymphoproliferative disease: Critical role of IL-6. European Journal of Immunology, 30(7), 2065-2073. https://doi.org/10.1002/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W